Amid plans to transfer manufacturing for an investigational vaccine to a souped-up plant in Pennsylvania, GSK is parting ways ...

With GSK kicking its research and development engine into high gear in recent years, a shuffling of the scientific priorities is only natural. | With GSK kicking its R&D engine into high gear in ...

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March ...

GSK multiplies ‘science x technology x culture’ to improve the R&D pipeline Multinational pharmaceutical company GlaxoSmithKline PLC is one of the largest drug developers in the world.

Forbes contributors publish independent expert analyses and insights. I cover news on drugs and R&D in the pharma industry via my Well, I was mistaken in that view, as I was told by Ms. Sarah ...

GlaxoSmithKline is set to lay off a small number of R&D employees at its Stevenage, U.K., site as part of a wider rethink of its drug development operation. The layoffs come as GSK revises its R&D ...

She added that GSK may be getting more bang per buck in terms of its R&D investment, with seven drugs in pre-registration phase compared with Celgene’s eight at the same stage of development.

Investing in companies that pay above average dividends has historically been a good investment strategy. Of course investors, specifically those looking for income, want more than just a current ...

GSK is a compelling value investment with a strong balance sheet, profitable drug line-up, and focus on vaccines. Click here to read more on GSK stock now.

Drugmaker GlaxoSmithKline plans to invest up to 130 million pounds ($216 million) in Africa over the next five years as it bets on the importance of the continent in driving long-term demand for ...

GSK delivered a stellar result for 1Q22, with turnover increasing 32% YOY (32% YOY constant exchange rate or CER) to £9.8 billion (10.5% vs. consensus).

March 31 (Reuters) - Drugmaker GlaxoSmithKline plans to invest up to 130 million pounds ($216 million) in Africa over the next five years as chronic diseases become more common among the continent ...